SFL CEO to co-chair DIAmond regulatory session at DIA Europe 2020 meeting
SFL’s CEO Shayesteh Fürst-Ladani representing the Medtech & Pharma Platform (MPP) will co-chair a DIAmond session at DIA Europe 2020 (#DMD11; 29 June‑ 3 July) on emerging and transforming technologies entitled “Does the current regulatory framework enable future science and technology along the product lifecycle?”. The session will be co-chaired by Sabine Atzor from Roche representing EFPIA, and panel members are Zaide Frias (European Medicines Agency), Ceri Thompson (DG CNECT, European Commission), Tapani Piha (FIPRA), and David Haerry (EATG).
Shayesteh is an expert on innovative medical devices, pharmaceuticals and associated regulations. She holds positions as President of the MPP, is a member of the expert group of the BIOPÔLE Digital Health Hub (DH2), and is a special coach for the Swiss Innovation Agency, Innosuisse. She also recently published an article on regulatory approval of software and digital healthcare devices with members of the SFL Medical Devices team.
Shayesteh would be happy to meet with you at SFL’s virtual booth, or you can contact SFL to arrange a call to discuss how SFL’s expert service areas, covering Medical Devices, Combination Products, Regulatory Affairs, Medical Affairs, Quality Assurance and Supply Chain, can support you in developing and implementing regulatory strategies for placing your innovative health ideas and new technologies onto the market.